Display Settings:

Format

Send to:

Choose Destination
    Cancer Imaging. 2006 Jul 4;6:83-94.

    Current staging of hepatocellular carcinoma: imaging implications.

    Source

    Department of Radiology, Division of Diagnostic Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. Priya.Bhosale@di.mdacc.tmc.edu

    Abstract

    The incidence of hepatocellular carcinoma has been rising in the USA in the past two decades. Hepatocellular carcinoma primarily affects older people and reaches its highest prevalence among those aged between 50 and 70 years. Chronic infection by the hepatitis B virus is the most common cause of this disease. Since hepatocellular carcinoma is an indolent tumor, it has a low life expectancy. In patients with suspected hepatocellular carcinoma, CT, MRI, and ultrasound techniques are useful for formulating the diagnosis based on vascularity and specific enhancement features. In this paper we will discuss the multimodal approach for diagnosis and surveillance of hepatocellular carcinoma. We will also furnish the latest staging and treatment, epidemiology, clinical presentation, pathology and laboratory findings in hepatocellular carcinoma.

    PMID:
    16829469
    [PubMed - indexed for MEDLINE]
    PMCID: PMC1693764
    Free PMC Article

    Images from this publication.See all images (11) Free text

    Figure 6
    Figure 7
    Figure 11
    Figure 2
    Figure 5
    Figure 1
    Figure 3
    Figure 8
    Figure 4
    Figure 10
    Figure 9

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk